A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.

Clinical trial NCT05188209 · UNKNOWN

Trial details

NCT number: NCT05188209
Sponsor: Shanghai Miracogen Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Gastric Cancer Advanced or Metastatic Gastroesophageal Junction Carcinoma

Start date: 2021-05-24
Primary completion: 2023-03-21
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.